Theraplix Report issue

For profit
Founded: Paris France (1931)
Status: Acquired by Rhone Poulenc (1956) → now Sanofi-Aventis (2004)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Indications

Overview

  • Highest Phase: None
  • # of Trials: 0
  • # of Trial APIs: 0